BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Q, Wu T, Ma XA, Jing L, Han LL, Guo H. Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Ther Clin Risk Manag 2018;14:991-8. [PMID: 29881281 DOI: 10.2147/TCRM.S160089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang N, Xu H, Li Q, Fang X, Liu J, Sui X, Zhang L, Jiang Y, Wang X. Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data. Cancer Manag Res 2020;12:5881-91. [PMID: 32765089 DOI: 10.2147/CMAR.S258875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Oral A, Sahin T. Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma. Sci Rep 2019;9:19087. [PMID: 31836844 DOI: 10.1038/s41598-019-55685-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]